Mucopolysaccharidosis type II (MPS II) is caused by mutations in the IDS gene, which encodes the lysosomal enzyme iduronate-2-sulfatase. In B20% of MPS II patients the disorder is caused by gross IDS structural rearrangements. We identified two male cases harboring complex rearrangements involving the IDS gene and the nearby pseudogene, IDSP1, which has been annotated as a low-copy repeat (LCR). In both cases the rearrangement included a partial deletion of IDS and an inverted insertion of the neighboring region. In silico analyses revealed the presence of repetitive elements as well as LCRs at the junctions of rearrangements. Our models illustrate two alternative consequences of rearrangements initiated by non-allelic homologous recombination of LCRs: resolution by a second recombination event (that is, Alu-mediated recombination), or resolution by non-homologous end joining repair. These complex rearrangements have the potential to be recurrent and may be present among those MSP II cases with previously uncharacterized aberrations involving IDS.
INTRODUCTION
Mucopolysaccharidosis type II (MPS II; Hunter syndrome; OMIM # 309900) is a rare X-linked recessive lysosomal storage disorder. It is caused by deficiency of the enzyme iduronate-2-sulfatase (IDS; EC 3.1.6.13), one of the enzymes in the pathway of heparan sulfate and dermatan sulfate degradation. The clinical severity of MPS II occurs along a spectrum with the severe form being characterized by progressive cognitive decline, developmental regression and involvement of multiple organ systems occurring during the first few years of life. Progressive respiratory and cardiac failure may lead to death in the first or second decade. In patients with the attenuated form, the central nervous system is not (or is minimally) compromised, although skeletal deformities and other organ involvement can be present to the same degree as in the severe form. Cardiac or respiratory failure may lead to death during the third to fourth decades of life. Treatment for MPS II is currently focused on enzyme replacement therapy and on the management of the clinical symptoms. 1 MPS II is caused by mutations in the IDS gene (RefSeq NM_000202.4), which consists of nine exons and spans B24 kb on chromosome Xq28.2. 2 Its 1650-bp open reading frame encodes the 550 amino-acid lysosomal enzyme iduronate-2-sulfatase. 3 A 1.4-kb alternative transcript that lacks exons 8 and 9 but contains an alternative terminal exon 7 has been reported, although the significance of this alternative form is not well known. 4 At 20 kb telomeric to the IDS locus, there is a predicted locus, LOC727913 (RefSeq XM_001126136), that is highly homologous to part of exon 2, intron 2 and exon 3 of the IDS gene ( Figure 1c) . [5] [6] [7] The IDSP1 locus, which is the only pseudogene of IDS in the human genome, is located B25 kb telomeric to IDS and spans 1.6 kb in an inverse orientation. IDSP1 is highly homologous to a 1.6-kb region within IDS intron 7 ( Figure 1c) . 8, 9 To date, more than 350 IDS disease-causing mutations have been described (Human Genome Mutation Database), 10 with the majority represented by missense, nonsense, splicing and small deletion mutations. Genomic rearrangements account for B20% of IDS cases. 10 There have been a number of previous reports documenting various rearrangements involving IDS and IDSP1. 8, 9 Among them is a common inversion involving low-copy repeats (LCRs) in IDS intron 7 and IDSP1 that has been observed in multiple independent pedigrees. 11 Also reported are large deletions of the IDS locus ranging from single or multiple exon deletions to deletions of the entire gene, with or without the involvement of neighboring genes. Complex rearrangements reported previously include recombination between the IDS gene and the IDSP1 pseudogene, 8, 9 a deletion with an inverted duplication, 12 and an Alu-mediated deletion with an insertion. 13 In particular, two highly homologous regions within IDS and IDSP1 appear to facilitate intrachromosomal recombination events leading to complex rearrangements. 5, 8, 14 These two regions span B1.6 kb and are designated as LCRs (UCSC Genome Browser, Human March 2006 Assembly (hg18); http://genome.ucsc.edu/). LCRs are thought to mediate non-allelic homologous recombination (NAHR) events resulting in recurrent rearrangements of a various number of loci. 15, 16 Non-homologous end joining (NHEJ) is another wellknown rearrangement repair mechanism that is thought to be facilitated by the presence of repetitive DNA sequences, such as Alu or LINE repeats, although the precise causal mechanisms remain elusive. [15] [16] [17] In this report we present two novel rearrangements involving the IDS gene and its pseudogene, IDSP1, in two unrelated patients with MPS II. One consists of a deletion including IDS exon 8 and an inverted duplication of an B49-kb region distal to IDS that is inserted into the deleted region. The other consists of an B36-kb deletion encompassing IDS exons 1 through 7 and an B8-kb deletion, interrupted by an inverted 2-kb region, and a point mutation that destroys the usual translation termination signal. In silico analysis of the breakpoints, aimed at identifying consensus sequences of motifs involved in complex rearrangements, suggests that the close proximity of the two LCRs, combined with the nearby Alu and other repetitive sequences, confers significant instability to this region, potentially contributing to these novel genomic rearrangements.
MATERIALS AND METHODS

Patient samples
Peripheral blood samples from the patients and one mother were submitted for IDS clinical testing to the DNA Diagnostic Laboratory at Baylor College of Medicine. The families subsequently gave their consent for further analysis of the pertinent genomic region on a research basis. This study was approved by the Baylor College of Medicine Institutional Review Board.
Mutation analysis
Genomic DNA was isolated from blood leukocytes on the AutoPure LS robotic workstation (Gentra Systems, Minneapolis, MN, USA) using a Puregene DNA isolation kit (Gentra Systems). Total RNA was isolated from whole blood using Trizol LS (Invitrogen, Carlsbad, CA, USA) as previously described. 18 PCR primers were designed for amplification of all coding exons and flanking intronic sequences of IDS (RefSeq NM_000202.2) and are available upon request. PCR products were sequenced using the Big Dye terminator version 3.1 chemistry on an ABI 3730 XL Genetic Analyzer (Applied Biosystems, Foster City, CA, USA).
Reverse transcriptase (RT)-PCR analysis
Three hundred nanograms of total RNA were reverse-transcribed in a 20 ml reaction volume with Superscript III Reverse Transcriptase (Invitrogen) according to the manufacturer's instructions. Primer sets and, when necessary, nested primer sets were designed based on the GenBank reference sequence NM_000202.2 at the exon-exon junctions. PCR was performed with FastTaq (Applied Biosystems). RT-PCR products were sequenced as described above.
Multiplex ligation-dependent probe amplification analysis
Dosage analysis of the IDS gene was performed by multiplex ligation-dependent probe amplification using commercially available reagents (SALSA P164 probe mix) and instructions from MRC-Holland (Amsterdam, The Netherlands). This probe mixture contains 11 probes specific to IDS and two probes specific to the IDSP1 pseudogene, along with other control fragments. Ligation products were amplified and resolved on an ABI 3730 XL Genetic Analyzer and the data were analyzed using Genescan software (Applied Biosystems). Patient data were normalized to gender-matched controls for copy-number differences using Gene Marker Software (Softgenetics, State College, PA, USA).
Affymetrix genome-wide SNP array 6.0 comparative genomic hybridization analysis Array-comparative genomic hybridization (array-CGH) using the Affymetrix Genome-Wide SNP Array 6.0 was performed according to the Genome-Wide Human SNP Nsp/Sty Assay Kit 5.0/6.0 protocol provided by the manufacturer (Affymetrix, Santa Clara, CA, USA). 19 The arrays were scanned using a GeneChip Scanner 3000 7G (Affymetrix) and results were analyzed using Genotyping Console version 2.1 software (Affymetrix).
Determination of rearrangement breakpoints
The rearrangement breakpoints were ascertained by PCR primer walking using FastTaq (Applied Biosystems) and the Expand Long Template PCR System (Roche Diagnostics, Indianapolis, IN, USA). PCR primers were designed based on the GenBank reference sequence NC_000023.9, and are listed in Table 1 . PCR products were sequenced as described above. All chromosome positions were determined using the Human March 2006 Assembly (hg18).
RESULTS
Clinical presentations of MPS II patients
The patient (case 1) is a 3-year-old European Caucasian male with clinical features consistent with a diagnosis of MPS II. He was born after a normal term pregnancy by Cesarean section to a 25-year-old mother. His birth weight was 3450 g. His Apgar scores were high, but on the second day of life he aspirated and developed respiratory distress requiring ventilator support for 2 weeks. In addition, he had mild jaundice, which persisted for the first month of life. The patient's development was globally delayed and he displayed progressive facial coarsening, hepatomegaly, joint stiffness, fine papular skin rash and an umbilical hernia. An echocardiogram showed mild thickening of the mitral valve. He developed hearing loss and was given hearing aids. Magnetic resonance imaging of the head showed generalized dilatation of perivascular spaces, confluent bi-hemispheric white matter, T-signal hyperintensity and mild narrowing of foramen magnum due to deformity of the dens and thickening of the ligamentous structures along the posterior aspect of the dens, but without impingement on the cervicomedullary junction. The skeletal survey was consistent with mild dysostosis multiplex. Urinary mucopolysaccharides elevated with excretion of dermatan and heparan sulfate, along with an analysis of IDS activity in peripheral blood leukocytes, confirmed the diagnosis of MPS II. The patient was started on enzyme replacement therapy at age 2.5 years. At age 3.5 years he presented with sleep abnormalities and was diagnosed with confusional arousals, without evidence of obstructive sleep apnea or electroencephalogram abnormalities suggesting seizures.
The second patient (case 2) is a 6-year-old male of Pakistani origin with clinical features consistent with a diagnosis of MPS II. This diagnosis was confirmed through biochemical enzyme analysis. Detailed clinical information could not be obtained for this patient.
Case 1-a case of a deletion and an inverted duplication Standard mutation analysis performed on a clinical basis failed to amplify IDS exon 8 with two different sets of PCR primers, which suggested the presence of a hemizygous deletion spanning exon 8.
Messenger RNA studies by RT-PCR analysis of IDS exons 6 through 9 (c.852 through c.1303) yielded the expected 452-bp product in two control samples, but no significant products were seen in the patient sample (Figure 1a, left) . However, nested RT-PCR with internal primers to amplify exons 7 through 9 (c.947 through c.1254) revealed a larger, 1.8-kb product in the patient sample and the expected 308-bp product in two controls (Figure 1a , middle). In nested RT-PCR experiments, two RT-PCR products, one of which was 1.8 kb as previously observed, and the other 1.1 kb, were observed in separate reactions for the patient sample (Figure 1a, right) . Sequence analysis of the longer RT-PCR product revealed that it contained an insertion of 1639 bp between IDS exons 7 and 9 ( Figure 1b ). This 1639-bp insertion aligned with six regions interspersed within a 10-kb genomic region that maps B50 kb telomeric to the IDS gene (Figures 1c and d) . These six regions are each flanked by AG nucleotides on the 5¢ ends and GT nucleotides on the 3¢ ends, suggesting that they could represent cryptic exons. The first four cryptic exons aligned with exons 2, 3, 4 and a portion of exon 5 of the putative gene, CXorf40A (Figure 1d ). The fifth cryptic exon aligned with a part of LOC100133153 in a reverse orientation. The sixth cryptic exon aligned with a portion of another putative gene, FLJ16423. The shorter RT-PCR product contained an 898-bp insertion between IDS exons 7 and 9. This 898-bp insertion aligned with the same first five cryptic exons derived from CXorf40A and LOC100133153 that were observed within the longer RT-PCR product; however. it was missing the sixth cryptic exon from FLJ16423 (Figure 1d) . Thus, the 1639-bp and 898-bp insert are likely to represent alternative splice isoforms. These data indicate that a genomic fragment of at least 10 kb (chrX:148 431 470-148 441 869) was inserted between IDS exons 7 and 9 in a reverse orientation. MLPA analysis confirmed the presence of the deletion of IDS exon 8 in the proband (Figure 2a ) and his carrier mother (Figure 2b ). In addition, one of the two IDSP1-specific probes showed a probe height ratio of B2 in the patient and of B1.5 in his mother relative to the corresponding peak in the control samples. This suggests that the insertion between IDS exons 7 and 9 may include a partially duplicated portion of the IDSP1 pseudogene, and that the lower probe height ratio for the mother is due to her being heterozygous for this mutation. In the attempt to delineate this rearrangement further, we conducted array-CGH analysis using the Affymetrix Genome-Wide SNP Array 6.0 (Figure 2c ). This analysis revealed a loss of two probes (red square in Figure 2c ), indicating the presence of a deletion involving IDS exon 8 and surrounding intronic regions, and a gain of an B45-kb (minimum) to an B75-kb (maximum) region including the IDSP1, CXorf40A, LOC100133153 and FLJ16423 loci (blue square in Figure 2c) .
We identified the breakpoints of this deletion/duplication by longrange PCR using various combinations of primers designed from the sequence surrounding this region, assuming that the duplicated fragment was inserted into the deleted region in a reverse orientation (Figure 3a) . Long-range PCR using a primer mapping to IDS intron 7 (F1, Table 1, Figure 3a) , and one between IDSP1 (that is, LCR) and CXorf40A (R1, Table 1, Figure 3a) , yielded a product only in the patient sample, but not in the control DNA (Figure 3b ), indicating that the distal or 5¢ breakpoint junction (in IDS intron 7) is within the LCRs. Based on the sequence similarity between the two LCRs, the recombination appears to have been mediated by identical 328-bp regions within the LCRs, chrX:148 377 890-148 378 207 in IDS and chrX:148 416 096-148 416 423 in IDSP1. Due to the absence of array-CGH probe coverage at the proximal or 3¢ end of the rearrangement (in IDS intron 8), a series of PCR primers within the 30-kb genomic region between the FLJ16423 and HSFX2 loci was tested in combination with primers mapping within IDS exon 9. One of the combinations, (F2 and R2, Table 1, Figure 3a) , yielded a PCR product unique to the patient sample (Figure 3b) . Junction sequence analysis revealed 9 bp of homology (5¢-TCAAGACCA-3¢) at chrX:148 465 246-148 465 254 and chrX:148 373 971-148 373 979, both located within Alu elements (Figure 3c ). An Alu repeat belonging to the S subfamily, AluSc, in the duplicated region (chrX:148 373 761-148 374 055) is flanked by L1MB3 LINE elements (chrX:148 373 068-148 373 760 and chrX:148 374 056-148 374 127) on both sides (Figures 1c  and 3a) . (Figures 1d and 3a) . The length of the L1MD2-AluSg-L1MD2 is 1257 bp. The overall similarity between the two L1-Alu-L1 regions, or the combination of an L1 element, an Alu repeat, and another L1 element, is 84%. The similarity between the two Alu repeats only is 98%. The total lengths of the duplicated and deleted segments are 49 159 and 6090 bp, respectively.
Case 2-a case of a complex rearrangement and a point mutation Standard mutation analysis failed to amplify IDS exons 1 through 7 with two different sets of PCR primers, which suggested the presence of a hemizygous deletion spanning exons 1 through 7. In addition, sequence analysis of exons 8 and 9 identified a hemizygous c.1652G4C nucleotide change in IDS exon 9 (Figure 4a) . The c.1652G4C substitution results in the replacement of the normal translation stop codon UGA, with a UCA serine codon (p.X551S). This single base-pair substitution is predicted to result in the addition of 17 amino acids to the IDS protein.
MLPA analysis confirmed the deletion of exons 1 through 7 (Figure 4c) , and also revealed a deletion of part of the IDSP1 region, suggesting the presence of a deletion partially involving the IDSP1 pseudogene. In addition, the MLPA probe that hybridizes to both IDS exon 3 and a homologous region within the locus, LOC727913 (Figure 4b) , showed a probe height ratio of B0.5 (pink box in Figure 4c ). As IDS exon 3 appears to be deleted, this suggests that the deletion is interrupted by the region that includes a portion of LOC727913. Array-CGH analysis revealed an B36-kb deletion encompassing the IDS locus and an B8-kb deletion distal to the IDS locus (Figures 4d and e) . Based on the genomic coordinates of the probes, this second deletion potentially could range from 7 to 14 kb in size. The B36 kb deletion encompasses IDS exons 1 through 7 and the B8-kb deletion includes a portion of IDSP1. These two deletions are interrupted by an B2-kb region that includes portions of LOC727913 and IDSP1 loci (Figure 4d) .
As recombination between the LCRs within IDS intron 7 and IDSP1 appears to be a recurrent and possibly common event, we first tested whether LCR-mediated recombination might be involved in this case. Long-range PCR with a forward primer mapping 5¢ or proximal to IDSP1, (F4, Table 1 , Figures 5a and b) , and a reverse primer mapping within IDS intron 8 (R4, Table 1 , Figures 5a and b) , yielded a distinct junction product in the patient but not in the control (Figure 5b ). Sequence analysis of this proximal breakpoint junction revealed that the same 328-bp homologous region within the LCRs in IDS intron 7 and IDSP1 may have mediated this rearrangement as well. No deletion or nucleotide insertion was found at the sequence around the breakpoint junction.
Based on array-CGH analysis and the evidence for recombination between two LCRs, we hypothesize a model in which the two deletions are interrupted by an inverted insertion of a region with identity to IDSP1 (Figure 5a ). Long-range PCR with primers mapping proximal to CXorf40A (F3, Table 1, Figure 5a) , and proximal to IDSP1, (R3, Table 1, Figure 5a ), yielded a unique product in the patient, but no product in the control (Figure 5b ). Sequence analysis revealed that the distal breakpoint joins a CT-rich low-complexity repeat (chrX:148 424 336-148 424 660) at nucleotide position chrX:148 424 658, to an AluSp element (chrX:148 414 067-148 414 377) at nucleotide position chrX:148 414 166 (Figure 5c ). There is no sequence homology at this junction, suggesting repair by NHEJ. The total sizes of the deletions are 36 275 and 8234 bp, respectively; the size of the insertion is 2248 bp.
DISCUSSION
In this study, we carried out detailed molecular analyses for two novel complex rearrangements involving the IDS locus in patients with MPS II. The first case involves an B49-kb duplication of a region telomeric to IDS that was inserted into a deleted region of IDS. The second case involves an interrupted deletion including IDS exons 1 through 7 and part of the IDSP1 region, and a point mutation that destroys the usual IDS termination codon. Junction analysis was facilitated by the use of array-CGH to assess the approximate locations of the breakpoints.
Collective junction analyses for the first case support our model that the insertion of a duplicated region may be mediated by a strand exchange involving the homologous LCR and L1-Alu-L1 regions (Figure 3a) . Interestingly, the 3 kb-deletion including exon 8 reported by Ricci et al. involves an L1-AluS in IDS intron 7 and AluSc in intron 8, the latter of which we propose to have participated in the Alumediated recombination event in our case. Although we present a model in which the duplicated insertion was derived from the distal region of its own strand through a loop formation, interchromatid or interchromosomal strand exchange is also a possibility. Because of the physical proximity, however, it would be more likely that the duplication was derived from its own strand. If this were the case, the strand exchange at the LCR would have to occur before the strand exchange at the L1-Alu-L1 to retain the region between LCRs in IDS and IDSP1. This raises the possibility that the Alu-mediated recombination was a subsequent event resulting from the genomic instability caused by recombination between LCRs. It is not clear why these two particular Alu sequences were chosen for the recombination event. There are 17 Alu repeats within this region and many of them are flanked by L1 LINE elements. Therefore, although this choice could have been stochastic, it may have involved an epigenetic mechanism. Nevertheless, considering the involvement of LCRs and L1-Alu-L1 repetitive elements, this particular complex rearrangement has the potential to be recurrent and may be present among those MSPII cases with previously uncharacterized aberrations involving IDS.
For the second case, we have evidence for NAHR occurring at the same LCRs as in the first case, and that the breakpoints are located within an AluSp element and a CT-rich region is consistent with NHEJ. Although CT-rich regions are not commonly recognized as frequent NHEJ sites, they may not be as stable as the other regions. Our data support a mechanism of coupled homologous and nonhomologous recombination initially proposed in an experimental system. 20 In this model, when double-strand breaks are introduced, the repair is initiated by homologous recombination but is completed by NHEJ. This model has been proposed to explain the mechanism of heterogeneous duplications of the PLP1 gene. 21 In our case, NAHR at the LCRs and NHEJ at the AluSp element and CT-rich region would have to occur as one event instead of two sequential events. Otherwise, if NAHR occurs without NHEJ, the region containing the AluSp would be deleted, and if NHEJ occurs without NAHR, IDSP1 would be deleted. Replication-based mechanisms such as FoSTeS, or fork stalling and template switching, 22 remain a possibility for case 1, but are unlikely for case 2 because there is no homology at this NHEJ junction. Thus, our findings support coupled homologous and nonhomologous recombination as a molecular mechanism explaining the complex rearrangement of our second case.
An important finding for this second case is the presence of a point mutation, c.1652G4C, which alters the normal stop codon, TGA, to a serine codon, TCA (p.X551S). This results in the predicted addition of 17 amino acids at the C-terminus of the protein. This change has thus far not been reported in the literature as a diseasecausing mutation, and it is not clear whether or to what extent this alteration might affect the biological activity of iduronate-2-sulfatase. We had reported previously a patient with Duchenne muscular dystrophy who carried a splicing mutation with an adjacent deletion of the DMD gene. 23 We proposed that the presence of the diseasecausing mutation might have elicited genomic instability by driving a deletion event in the attempt to correct the pre-existing mutation. Although it is highly speculative, it is possible that the presence of the stop codon mutation might have had a role in the recombination event in our present case.
Among IDS rearrangements, LCR-mediated NAHR that does not involve other regions appears to be relatively common. 9, 11 Herein we present two cases of IDS complex rearrangements, that we propose to involve LCR-mediated NAHR, but to be completed by different mechanisms. It is not known what triggers such complex rearrangements or how complex rearrangements might proceed once initiated. Additional case studies, not only involving IDS but also other loci, are required to elucidate further the processes that might promote such complex rearrangements. These studies are likely to be facilitated as array-CGH analysis becomes more routine in clinical diagnostic testing for various genetic disorders.
